| Robert T Howard Iii, MD | |
|
24 Miles Center Way, Damariscotta, ME 04543-4047 | |
| (207) 563-4700 | |
| (207) 563-4019 |
| Full Name | Robert T Howard Iii |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 34 Years |
| Location | 24 Miles Center Way, Damariscotta, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689649204 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ottumwa Health Group Llc | 3971629924 | 27 |
News Archive
More than 20 million people develop heart disease globally each year, but there is only one cardiac rehab spot for every 12 of those patients to prevent another heart event, according to new research from York University.
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
Physicians at St. John Hospital and Medical Center have enrolled the first patient in Michigan in LEVANT2, a global, multicenter, randomized clinical trial evaluating the safety and effectiveness of the Moxy- Drug Coated Balloon for the treatment of peripheral arterial disease.
Ground-breaking research led by University of Limerick has revealed for the first time that the immune system directly links personality to long-term risk of death.
› Verified 7 days ago
| Entity Name | Ottumwa Health Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386956290 PECOS PAC ID: 3971629924 Enrollment ID: O20100927001257 |
News Archive
More than 20 million people develop heart disease globally each year, but there is only one cardiac rehab spot for every 12 of those patients to prevent another heart event, according to new research from York University.
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
Physicians at St. John Hospital and Medical Center have enrolled the first patient in Michigan in LEVANT2, a global, multicenter, randomized clinical trial evaluating the safety and effectiveness of the Moxy- Drug Coated Balloon for the treatment of peripheral arterial disease.
Ground-breaking research led by University of Limerick has revealed for the first time that the immune system directly links personality to long-term risk of death.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert T Howard Iii, MD 24 Miles Center Way, Damariscotta, ME 04543-4047 Ph: (207) 563-4700 | Robert T Howard Iii, MD 24 Miles Center Way, Damariscotta, ME 04543-4047 Ph: (207) 563-4700 |
News Archive
More than 20 million people develop heart disease globally each year, but there is only one cardiac rehab spot for every 12 of those patients to prevent another heart event, according to new research from York University.
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
Physicians at St. John Hospital and Medical Center have enrolled the first patient in Michigan in LEVANT2, a global, multicenter, randomized clinical trial evaluating the safety and effectiveness of the Moxy- Drug Coated Balloon for the treatment of peripheral arterial disease.
Ground-breaking research led by University of Limerick has revealed for the first time that the immune system directly links personality to long-term risk of death.
› Verified 7 days ago
Deborah C. Eisenberg, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 24 Miles Center Way, Damariscotta, ME 04543 Phone: 207-563-4700 Fax: 207-563-4019 | |
Patrick M. O'brien, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 24 Miles Center Way, Damariscotta, ME 04543 Phone: 207-563-1234 | |
William D Riley, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 35 Miles St, Miles Medical Group Billing, Damariscotta, ME 04543 Phone: 207-563-4511 Fax: 207-563-4103 |